Life Insurance
Consensus Index

AI Consensus Fit Review

New York Life Whole Life Insurance Fit Review for Dividends

New York Life is a strong fit for a buyer who wants participating Whole Life Insurance for Dividends and prioritizes insurer financial strength, a long reported dividend record, and flexible premium-payment design.

Research: 2026-09-207 usable platform responsesRead the methodology ↗

Share

Answer Capsule

New York Life is a strong fit for a buyer who wants participating Whole Life Insurance for Dividends and prioritizes insurer financial strength, a long reported dividend record, and flexible premium-payment design. All seven platforms that named it in the ranking stage placed it in their recommendations, with an average listed rank of 2.29 and a best rank of 2. The strongest reason to consider it is its reported 172nd consecutive annual dividend and top-tier financial-strength ratings. The main limitation is that dividends are not guaranteed, no public buyer-specific premium exists, and the company's 2026 dividend interest rate of 6.40% is reported as second to MassMutual's 6.60%.

Research Snapshot

FieldFinding
Platform mentions in ranking stage7 of 7 included platforms
Share of included platform responses100% (7 of 7)
Average listed rank2.29
Best listed rank2
Relevant product/model/planNew York Life Custom Whole Life, a participating whole life policy with dividend options; exact design must be confirmed through a state-specific illustration
Overall use-case fitStrong (six platforms rated "strong," one rated "good")
Research date2026-09-20

Why New York Life Qualified for This Study

Questions This Section Answers

  • Why did New York Life qualify as a top carrier for participating whole life insurance with dividends?
  • Does New York Life's mutual structure and dividend record make it worth comparing for whole life dividends?

New York Life qualified because every platform that named it in the ranking stage placed it among its recommended carriers for participating whole life insurance with a dividend focus. It appeared in 7 of 7 included platform responses, with an average listed rank of 2.29 and a best rank of 2 [1].

The qualification rests on four factors the platforms repeatedly cited. First, New York Life is a mutual life insurer owned by policyholders, which platforms treated as structurally aligned with dividend-paying participating policies [4]. Second, the company reports an estimated $2.78 billion dividend for 2026 and its 172nd consecutive annual dividend [2]. Third, it holds top-tier financial-strength ratings from all four major agencies [7]. Fourth, its Custom Whole Life product allows a selected premium-paying period rather than premiums for life [10].

The category criteria for this study required carriers with established participating whole life programs and an understanding that future dividends are not guaranteed. New York Life met both: platforms described a long dividend record while consistently disclosing that dividends are nonguaranteed [12].

The Product, Model, Plan, or Service Most Relevant to Whole Life Insurance for Dividends

Questions This Section Answers

  • Which New York Life policy is best for a buyer who wants participating whole life dividends?
  • How does New York Life Custom Whole Life let a buyer choose a shorter premium-payment period?

The most relevant offering is New York Life Custom Whole Life, a participating whole life policy with dividend options. Platforms supplied several product labels, but the most specific verifiable product for this use case is Custom Whole Life with participating dividend provisions, subject to state-specific confirmation [14].

Custom Whole Life lets the buyer select a premium-paying period instead of paying for life. New York Life describes it as providing guaranteed benefits and premiums with a shorter selected premium-paying period [17]. One platform reported payment periods as short as 5 years, ending before age 75, with shorter periods requiring higher annual premiums [18]. Another reported a choice of payment years between 5 and 35 [19]. These ranges conflict, so the exact available periods must be confirmed in a state-specific illustration.

The applicable policy form is generally ICC18217-50P (4/18), subject to state variations [17]. Coverage ranges were reported as $50,000 to $1 million for Custom Whole Life, with one platform noting "$1 million+" and another citing a $1 million cap [20]. That conflict is unresolved in the supplied evidence.

Dividend options include paid-up additions, accumulation at interest, premium application, cash, and loan-interest-related options, subject to policy terms [21]. Paid-up additions can increase coverage without increasing scheduled premiums [23].

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about New York Life for whole life insurance dividends?
  • Is New York Life's dividend history and financial strength consistently rated across AI platforms?

Platforms agreed unanimously on several points. All seven that named New York Life rated it a strong or good fit for this use case, and all seven cited its dividend record and financial strength as advantages [25].

They agreed the company reports a long, unbroken dividend record. New York Life states it has paid dividends on participating policies every year since 1854, and the company announced an estimated $2.78 billion dividend for 2026, described as its 172nd consecutive annual dividend [32]. One platform reported the 2024 record dividend was $2.2 billion [29], and another reported a $2.5 billion dividend declared for 2025 [34].

They agreed on top-tier financial strength. New York Life reports A++ from A.M. Best, AAA from Fitch, Aa1 from Moody's, and AA+ from S&P [30]. A.M. Best independently affirmed an A++ Superior financial-strength rating and aaa long-term issuer-credit rating in July 2026 [37]. Fitch affirmed the IFS at AAA with a stable outlook [39], and S&P affirmed AA+ ratings [40].

They agreed dividends are not guaranteed and that policy economics are individualized [41].

Where the AI Platforms Disagreed or Were Uncertain

Platforms disagreed or were uncertain on several material points.

Dividend interest rate ranking. One platform reported New York Life's 2026 dividend interest rate at 6.40%, up 20 basis points from 2025, ranking second behind MassMutual at 6.60% and ahead of Guardian (6.25%), Penn Mutual (6.00%), and Northwestern Mutual (5.75%) [43]. Another reported the same 6.40% figure [45]. These are independent-review figures, not company-confirmed rates for a specific policy.

Dividend streak length. One platform reported the streak as 166 consecutive years in one source and 172 years in another, calling the exact duration unverified [46]. The company-reported figure is 172 years [47].

Loan recognition method. One platform stated New York Life uses non-direct recognition, meaning dividends continue accruing on the full cash value balance including borrowed amounts [48]. Another platform said the loan recognition method was not specified in available sources [46]. A third noted that specific riders or older legacy contracts may have handled loan interest recognition differently [50]. This conflict matters for buyers planning policy loans.

Early cash value competitiveness. One platform reported that illustrated comparisons show Penn Mutual's Accumulation Whole Life may produce higher actual cash value by years 5–10 despite a lower stated dividend rate [51]. This is a partial-support source.

Coverage limits and payment periods. Reported Custom Whole Life coverage ranged from $50,000 to $1 million, with one source saying "$1 million+" and another citing a $1 million cap [52]. Reported payment periods ranged from 5–25 years or to age 65/100 in one source and 5–35 years in another [53].

Premium Deposit Account rate. The last documented Premium Deposit Account interest rate was 2.4%, but sources did not confirm the current 2026 rate [55].

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What dividend options does New York Life Custom Whole Life offer for cash value growth?
  • Does New York Life's non-direct recognition design matter for a buyer using policy loans?

The features most relevant to a dividend-focused buyer are dividend options, premium-period flexibility, and loan treatment.

Dividend options let the policyholder direct how dividends are used. New York Life's dividend-election form lists paid-up additions, accumulation at interest, premium application, cash, and loan-interest-related options, subject to policy terms [56]. Paid-up additions can increase death benefit and cash value without increasing scheduled premiums [57].

Premium-period flexibility is the core of Custom Whole Life. The buyer selects a payment period rather than paying for life, and fewer payments generally mean higher premiums [59]. One platform described the design as suited to buyers emphasizing early funding and long-term cash value [61].

Loan treatment is disputed. One platform described New York Life as a non-direct recognition carrier, meaning an outstanding policy loan does not reduce the dividend credited to cash value [62]. Another platform could not confirm the method [64]. New York Life states that policy loans accrue interest and that loans or withdrawals reduce available cash surrender value and death benefit [65].

A Premium Deposit Account allows pre-funding up to 9 annual premiums with locked-in interest, but it was reported as unavailable in IL, IN, KS, PA, TN, TX, and WA [66].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does New York Life Custom Whole Life cost per month, and what fees apply?
  • What charges and surrender terms should a buyer confirm before signing a New York Life whole life contract?

No public buyer-specific price exists for New York Life Custom Whole Life. Premiums must be quoted after underwriting and depend on age, health, coverage amount, state, riders, payment period, and policy design [68]. Every platform that addressed pricing rated its confidence low or moderate.

Known costs and charges reported across platforms:

  • Scheduled policy premiums, individualized and not publicly stated [68].
  • A disclosed 5% to 35% premium expense charge for the Option to Purchase Paid-Up Additions rider, applied to additional premium before the remainder is applied to the policy [71].
  • A disclosed $100 living-benefits rider fee when exercised, up to a maximum of $150 [71].
  • Optional rider charges, including disability waiver and chronic-care-related riders [68].
  • Policy-loan interest that accrues when loans are used [73].
  • A 10% withdrawal penalty on the remaining balance for full withdrawals from the Premium Deposit Account during the agreement period [74].
  • Possible surrender charges or reduced net cash value on surrender, depending on policy duration and contract terms [68].

Contract terms reported: policy guarantees depend on timely premium payments and the claims-paying ability of New York Life Insurance Company; dividends are nonguaranteed and may be paid only to eligible participating policy owners; surrender, withdrawal, or loan activity can reduce cash value and death benefit; and state-specific policy forms, riders, charges, and availability may differ [68]. A free-look period typically ranges from 10 to 30 days depending on state [75].

One platform reported that policies with annual premiums exceeding $150,000 for adults, or $100,000 for ages 0–17, require traditional underwriting with medical and lab tests, and that a medical exam is required at $100,000+ coverage under some conditions [76].

Best Suited For

Questions This Section Answers

  • Who is New York Life Custom Whole Life best suited for among dividend-focused whole life buyers?
  • Is New York Life a good choice for a buyer who wants a shorter premium-payment period?

New York Life is best suited for buyers who want participating whole life from a large mutual insurer with a long reported dividend-paying history and top-tier financial-strength ratings [77].

Platforms most consistently identified these buyer profiles:

  • Buyers seeking participating whole life from a large mutual insurer with a long reported dividend-paying history [77].
  • Buyers who want Custom Whole Life's shorter premium-paying-period options, including designs commonly illustrated over 10 or 20 years [77].
  • Buyers who may use dividends for paid-up additions and want to compare strong insurer financial-strength ratings [82].
  • Buyers prioritizing a mutual company ownership structure [80].
  • Buyers planning to use policy loans who want non-direct recognition dividend treatment, subject to confirming the current contract language [85].
  • High-net-worth buyers and those in advanced life insurance planning such as estate or business succession strategies [87].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose New York Life for whole life insurance dividends?
  • Is New York Life a poor fit for a buyer who wants online quotes or the lowest-cost coverage?

New York Life is probably not best suited for buyers seeking the lowest-cost temporary death-benefit coverage, buyers who need transparent online pricing before underwriting, or buyers who prioritize investment liquidity or market-linked growth over guaranteed insurance benefits and participating-policy economics [88].

Platforms also flagged these buyer profiles as poor fits:

  • Buyers seeking the absolute highest dividend interest rate in 2026, since MassMutual was reported at 6.60% versus New York Life's 6.40% [91].
  • Consumers wanting online quotes or transparent pricing without agent engagement [89].
  • Buyers who want standardized online pricing without an agent illustration [90].
  • Buyers who strictly value short-term cash value growth efficiency over long-term dividend consistency [89].
  • Buyers seeking guaranteed dividend amounts [94].
  • Buyers who want completely flexible paid-up-addition premium structures without strict overfunding rules [96].

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to New York Life for a buyer who wants the highest 2026 dividend interest rate?
  • When would a term or nonparticipating policy be better than New York Life Custom Whole Life?

Another option may be better in several specific situations the platforms identified.

If the buyer prioritizes the absolute highest 2026 dividend interest rate, MassMutual was reported at 6.60% versus New York Life's 6.40% [97]. If the buyer wants the fastest early cash value growth in years 5–10, one platform reported that Penn Mutual's Accumulation Whole Life may produce higher actual cash value despite a lower stated dividend rate [99]. If the buyer needs both direct and non-direct recognition loan options, Guardian was cited as offering both explicitly [98]. If the buyer prioritizes the largest absolute dividend payout scale, Northwestern Mutual was reported at $9.2 billion total in 2026, with $7.9 billion to whole life [98].

A conventional term policy is better when the buyer primarily needs large, low-cost temporary death-benefit protection rather than permanent cash value and dividends [100]. A nonparticipating or market-linked permanent policy may be better when the buyer prioritizes different guarantees, liquidity features, or market exposure, but those alternatives involve different risks and should not be treated as direct dividend-whole-life substitutes [100]. A guaranteed universal life or non-par whole life may be preferable if the buyer seeks purely guaranteed cash value without any interest-sensitive components [101].

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with New York Life before signing a Custom Whole Life contract?
  • How can a buyer compare New York Life's illustration against other participating whole life carriers?

Before signing, a buyer should verify these items, drawn from the platforms' own verification lists [102].

  • Is the proposed policy participating, and which legal insurer issues it in the buyer's state?
  • What are the guaranteed cash value and death-benefit schedules, excluding all dividends and other nonguaranteed values?
  • What dividend scale and dividend-interest assumptions are used, and how sensitive are results to lower-dividend scenarios?
  • Which dividend option is recommended: paid-up additions, cash, accumulation at interest, premium reduction, or loan-interest payment?
  • What are the exact premium-paying period, annual premium, out-of-pocket paid-up-addition premiums, and total planned funding?
  • What is the policy's guaranteed and illustrated break-even point and internal rate of return at ages 65, 75, 85, and life-expectancy assumptions?
  • What are the loan interest rate, direct-recognition treatment, repayment requirements, and consequences of an outstanding loan at death or lapse?
  • Are there surrender charges, premium expense charges, rider charges, or other deductions, and for how many years?
  • Could the proposed funding create a Modified Endowment Contract, and what tax consequences would follow?
  • What happens if premiums stop early, dividends are lower than illustrated, or the buyer changes the dividend election?
  • Does the policy include or require the Option to Purchase Paid-Up Additions rider, and what state-specific charge applies?
  • How often must the buyer fund the paid-up-addition rider to keep it from lapsing or requiring new medical underwriting?
  • How does this illustration compare with at least two other established participating whole-life insurers using identical assumptions?

Final AI Consensus Verdict

New York Life is a strong fit for a buyer who wants participating whole life insurance for dividends and prioritizes insurer financial strength, a long reported dividend record, and flexible premium-payment design. All seven platforms that named it in the ranking stage placed it in their recommendations, with an average listed rank of 2.29 and a best rank of 2. Six platforms rated the fit "strong" and one rated it "good."

The consensus rests on a reported 172nd consecutive annual dividend, an estimated $2.78 billion 2026 dividend, top-tier financial-strength ratings from all four major agencies, and Custom Whole Life's premium-period flexibility [107]. The consensus also carries a consistent qualification: dividends are not guaranteed, no public buyer-specific premium exists, and the 2026 dividend interest rate of 6.40% was reported as second to MassMutual's 6.60% [110].

The purchase decision should depend on a state-specific illustration showing guaranteed values separately from current-dividend values, plus comparison with other participating mutual insurers. Dividends and policy performance are not guaranteed.

How This Review Was Produced

This review was produced from a structured research run dated 2026-09-20. Seven AI platforms evaluated which life insurance carriers they would recommend for a consumer seeking participating whole life insurance who considers dividend history, financial strength, policy design, and dividend use especially important. New York Life was named by all seven platforms in the ranking stage and was evaluated for fit against the stated use case.

Each platform supplied its own fit assessment, strengths, limitations, pricing and terms, and verification questions. This article synthesizes those platform-reported findings, preserves their conflicts and uncertainties, and cites each factual claim to the platform response that supplied it. Citations are platform-reported evidence, not independently verified facts.

Methodology Limitations

Several limitations apply to this review.

  • Platform-reported research dates differ from the authoritative run date of 2026-09-20. One platform reported a research date of 2026-06-01; the others reported 2026-09-21. These are provenance metadata and do not independently prove freshness.
  • All included platforms evaluated fit, but the platform-mention count reflects only platforms that named New York Life during ranking discovery.
  • The supplied URLs were collected from platform responses and were not independently validated by the writer stage.
  • Citations are platform-reported evidence, not independently verified facts. Claims from platforms without search enabled require explicit verification before being described as current facts.
  • Conflicting product names, coverage limits, payment-period ranges, and loan-recognition descriptions were not resolved by guessing; buyers should verify each item directly.
  • No public standardized premium, internal rate of return, dividend scale, or policy-specific break-even result was verified for this use case.
  • Company-reported dividend totals and consecutive-dividend history do not establish that dividends will continue at the same level or that every policy receives the same result.
  • AI-platform agreement does not prove product quality.

Sources

Company-Owned Sources

Independent Sources

Other Sources

  • Additional AI research evidence111 records
    1. AI research evidence record anthropic:source-1
    2. AI research evidence record openai:c3
    3. AI research evidence record perplexity:c7
    4. AI research evidence record deepseek:nyl_about
    5. AI research evidence record kimi:nyl-dividends
    6. AI research evidence record anthropic:source-3
    7. AI research evidence record anthropic:source-16
    8. AI research evidence record perplexity:c15
    9. AI research evidence record google:source_ratings
    10. AI research evidence record openai:c2
    11. AI research evidence record anthropic:source-32
    12. AI research evidence record perplexity:c2
    13. AI research evidence record deepseek:nyl_dividend_options
    14. AI research evidence record openai:c1
    15. AI research evidence record anthropic:source-32
    16. AI research evidence record google:source_custom_whole_life
    17. AI research evidence record openai:c2
    18. AI research evidence record anthropic:source-35
    19. AI research evidence record google:source_value_penguin
    20. AI research evidence record anthropic:source-29
    21. AI research evidence record openai:c4
    22. AI research evidence record deepseek:nyl_dividend_options
    23. AI research evidence record openai:c5
    24. AI research evidence record google:source_pua_options
    25. AI research evidence record anthropic:source-1
    26. AI research evidence record deepseek:nyl_dividends
    27. AI research evidence record google:source_dividend_history
    28. AI research evidence record grok:web:2
    29. AI research evidence record kimi:nyl-dividends
    30. AI research evidence record openai:c3
    31. AI research evidence record perplexity:c7
    32. AI research evidence record perplexity:c2
    33. AI research evidence record anthropic:source-3
    34. AI research evidence record anthropic:source-21
    35. AI research evidence record anthropic:source-16
    36. AI research evidence record google:source_ratings
    37. AI research evidence record openai:c6
    38. AI research evidence record anthropic:source-10
    39. AI research evidence record perplexity:c4
    40. AI research evidence record perplexity:c11
    41. AI research evidence record deepseek:naic_buyer_guide
    42. AI research evidence record openai:c1
    43. AI research evidence record anthropic:source-8
    44. AI research evidence record anthropic:source-26
    45. AI research evidence record grok:web:4
    46. AI research evidence record kimi:nyl-dividends
    47. AI research evidence record openai:c3
    48. AI research evidence record anthropic:source-5
    49. AI research evidence record google:source_non_direct_rec
    50. AI research evidence record google:source_reddit_nyl_work
    51. AI research evidence record kimi:insuranceandestates-massmutual
    52. AI research evidence record anthropic:source-29
    53. AI research evidence record anthropic:source-32
    54. AI research evidence record google:source_value_penguin
    55. AI research evidence record anthropic:source-31
    56. AI research evidence record openai:c4
    57. AI research evidence record openai:c5
    58. AI research evidence record google:source_pua_options
    59. AI research evidence record openai:c7
    60. AI research evidence record anthropic:source-32
    61. AI research evidence record openai:c1
    62. AI research evidence record anthropic:source-5
    63. AI research evidence record google:source_non_direct_rec
    64. AI research evidence record kimi:nyl-dividends
    65. AI research evidence record openai:c8
    66. AI research evidence record anthropic:source-31
    67. AI research evidence record anthropic:source-34
    68. AI research evidence record openai:c1
    69. AI research evidence record anthropic:source-29
    70. AI research evidence record deepseek:nyl_custom
    71. AI research evidence record openai:c9
    72. AI research evidence record google:source_pua_charge
    73. AI research evidence record openai:c8
    74. AI research evidence record anthropic:source-31
    75. AI research evidence record deepseek:naic_buyer_guide
    76. AI research evidence record anthropic:source-30
    77. AI research evidence record openai:c1
    78. AI research evidence record anthropic:source-1
    79. AI research evidence record perplexity:c7
    80. AI research evidence record kimi:nyl-dividends
    81. AI research evidence record google:source_custom_whole_life
    82. AI research evidence record openai:c5
    83. AI research evidence record anthropic:source-16
    84. AI research evidence record deepseek:nyl_about
    85. AI research evidence record google:source_non_direct_rec
    86. AI research evidence record anthropic:source-5
    87. AI research evidence record anthropic:source-39
    88. AI research evidence record openai:c1
    89. AI research evidence record anthropic:source-29
    90. AI research evidence record perplexity:c7
    91. AI research evidence record anthropic:source-8
    92. AI research evidence record kimi:insurancegeek-2026
    93. AI research evidence record google:source_money_mag
    94. AI research evidence record grok:web:2
    95. AI research evidence record perplexity:c2
    96. AI research evidence record google:source_pua_rules
    97. AI research evidence record anthropic:source-8
    98. AI research evidence record kimi:insurancegeek-2026
    99. AI research evidence record kimi:insuranceandestates-massmutual
    100. AI research evidence record openai:c1
    101. AI research evidence record deepseek:nyl_custom
    102. AI research evidence record openai:c1
    103. AI research evidence record anthropic:source-29
    104. AI research evidence record perplexity:c7
    105. AI research evidence record kimi:nyl-dividends
    106. AI research evidence record google:source_pua_rules
    107. AI research evidence record openai:c3
    108. AI research evidence record anthropic:source-16
    109. AI research evidence record perplexity:c7
    110. AI research evidence record anthropic:source-8
    111. AI research evidence record kimi:insurancegeek-2026

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 20, 2026
Platforms analyzed
7
Source records
59
Ranking mentions
7 of 7
Platform share
100%
Final consensus rank
#2

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

29 independent · 29 company-owned · 1 unclear

Evidence support

53 direct · 6 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

4861ec89e7762d875c482e244390ffefa3358181261ada616d5fb77cbdc2b8ea